Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R Myeloma
Clinical trial NCT06066359 · RECRUITING
Trial details
- NCT number
- NCT06066359
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2028-08-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.